CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled / 38 target
Drug / intervention
Felix NeuroAI Wristbanddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05842434
NCT05842434N/ACompletedOn Track (1.0/mo)Completion was 31mo ago
CompareCT.gov

Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor

Fasikl Inc.·interventional·Posted May 6, 2023·Updated Jun 15, 2026

In Brief

A clinical study evaluating Felix NeuroAI Wristband for Essential Tremor and Parkinson Disease. Completed, enrolled 38 participants across 2 sites.

Detailed Summary

A prospective, open-label, multi-center pilot study designed to evaluate the safety and effectiveness of the Felix system in the relief of upper limb tremors in adults with essential tremor and Parkinson's disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEssential Tremor, Parkinson Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMay 6, 2023
Enrollment StartJun 6, 2023
Primary CompletionNov 29, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.2 years ago

Arms & Interventions

Essential Tremorexperimental

Patients with essential tremors

Device: Felix NeuroAI Wristband
Parkinson's Diseaseexperimental

Patients with Parkinson's disease

Device: Felix NeuroAI Wristband

Interventions

Felix NeuroAI Wristbanddevice

Felix is a wrist-worn, noninvasive, transcutaneous neurostimulation system intended for daily use to suppress hand tremors. An artificial intelligence (AI) algorithm will automatically adjust the stimulation based on each patient's tremor throughout the day.